Studies

144

Enrolment

67.2M

Countries

53

MRNA

$218.01 +738.2%

FAERS

796

Live APIs

TBA

Trials & phases

Program usage over time, phase distribution and the conditions Moderna studies most.

Program usage by start year

· studies initiated vs cumulative enrolment target

Phase mix

· share of registered studies

Phase 161

Phase 252

Phase 329

N/A24

Phase 47

Early Phase 11

Most studied conditions

· registered study count